Search

Author/Creator Valerius, Thomas

1. An IgG3 switch variant of rituximab mediates enhanced complement‐dependent cytotoxicity against tumour cells with low CD20 expression levels. (7th January 2013)

Authors:
Rösner, Thies; Derer, Stefanie; Kellner, Christian; Dechant, Michael; Lohse, Stefan; Vidarsson, Gestur; Peipp, Matthias; Valerius, Thomas
Journal:
British journal of haematology
Issue:
Volume 161:Number 2(2013:Apr.)
Page Start:
282
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity. (27th April 2017)

Authors:
Lohse, Stefan; Loew, Sebastian; Kretschmer, Anna; Jansen, J. H. Marco; Meyer, Saskia; ten Broeke, Toine; Rösner, Thies; Dechant, Michael; Derer, Stefanie; Klausz, Katja; Kellner, Christian; Schwanbeck, Ralf; French, Ruth R.; Tipton, Thomas R. W.; Cragg, Mark S.; Schewe, Denis M.; Peipp, Matthias;...
Journal:
British journal of haematology
Issue:
Volume 181:Number 3(2018)
Page Start:
413
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions. Issue 8 (18th June 2021)

Authors:
Baumann, Niklas; Rösner, Thies; Jansen, J. H. Marco; Chan, Chilam; Marie Eichholz, Klara; Klausz, Katja; Winterberg, Dorothee; Müller, Kristina; Humpe, Andreas; Burger, Renate; Peipp, Matthias; Schewe, Denis M.; Kellner, Christian; Leusen, Jeanette H. W.; Valerius, Thomas
Journal:
Cancer science
Issue:
Volume 112:Issue 8(2021)
Page Start:
3029
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30. (2nd January 2016)

Authors:
Kellner, Christian; Günther, Andreas; Humpe, Andreas; Repp, Roland; Klausz, Katja; Derer, Stefanie; Valerius, Thomas; Ritgen, Matthias; Brüggemann, Monika; van de Winkel, Jan GJ; Parren, Paul WHI; Kneba, Michael; Gramatzki, Martin; Peipp, Matthias
Journal:
Oncoimmunology
Issue:
Volume 5:Number 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Higher risk for chronic graft‐versus‐host disease (GvHD) in HLA‐G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective study. (27th July 2022)

Authors:
Neuchel, Christine; Gowdavally, Sowmya; Tsamadou, Chrysanthi; Platzbecker, Uwe; Sala, Elisa; Wagner‐Drouet, Eva; Valerius, Thomas; Kröger, Nicolaus; Wulf, Gerald; Einsele, Hermann; Thurner, Lorenz; Schaefer‐Eckart, Kerstin; Freitag, Sebastian; Casper, Jochen; Dürholt, Mareike; Kaufmann, Martin; H...
Journal:
HLA
Issue:
Volume 100:Number 4(2022)
Page Start:
349
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. IgA EGFR antibodies mediate tumour killing in vivo. Issue 8 (5th August 2013)

Authors:
Boross, Peter; Lohse, Stefan; Nederend, Maaike; Jansen, Johannes Hendrik Marco; van Tetering, Geert; Dechant, Michael; Peipp, Matthias; Royle, Louise; Liew, Li Phing; Boon, Louis; van Rooijen, Nico; Bleeker, Wim K.; Parren, Paul W. H. I.; van de Winkel, Jan G. J.; Valerius, Thomas; Leusen, Jeanet...
Journal:
EMBO molecular medicine
Issue:
Volume 5:Issue 8(2013:Aug.)
Page Start:
1213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting. Issue 1 (2nd January 2016)

Authors:
Meyer, Saskia; Nederend, Maaike; Jansen, J.H. Marco; Reiding, Karli R.; Jacobino, Shamir R.; Meeldijk, Jan; Bovenschen, Niels; Wuhrer, Manfred; Valerius, Thomas; Ubink, Ruud; Boross, Peter; Rouwendal, Gerard; Leusen, Jeanette H.W.
Journal:
MAbs
Issue:
Volume 8:Issue 1(2016)
Page Start:
87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. New insights in Type I and II CD20 antibody mechanisms‐of‐action with a panel of novel CD20 antibodies. (22nd February 2018)

Authors:
Meyer, Saskia; Evers, Mitchell; Jansen, Johannes H. M.; Buijs, Jos; Broek, Blanca; Reitsma, Stephanie E.; Moerer, Petra; Amini, Mojtaba; Kretschmer, Anna; ten Broeke, Toine; den Hartog, Marcel T.; Rijke, Mark; Klein, Christian; Valerius, Thomas; Boross, Peter; Leusen, Jeanette H. W.
Journal:
British journal of haematology
Issue:
Volume 180:Number 6(2018)
Page Start:
808
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies. Issue 1 (1st January 2020)

Authors:
Evers, Mitchell; Ten Broeke, Toine; Jansen, J.H. Marco; Nederend, Maaike; Hamdan, Firas; Reiding, Karli R.; Meyer, Saskia; Moerer, Petra; Brinkman, Iris; Rösner, Thies; Lebbink, Robert Jan; Valerius, Thomas; Leusen, Jeanette H.W.
Journal:
MAbs
Issue:
Volume 12:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗